Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Journal of the American College of Cardiology
|
February 25, 2003
Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system
Philip B Adamson, Anthony Magalski, Frieder Braunschweig, et al.
Circulation
|
September 28, 2011
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)
Giuseppe Mancia, Helmut Schumacher, Josep Redon, et al.
Global Heart
|
August 28, 2019
A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes
Sharon Mitchell, Belma Malanda, Albertino Damasceno, et al.
Diabetes Care
|
April 9, 2013
Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE)
Eva M Lonn, Jackie Bosch, Rafael Diaz, et al.
Diabetes Care
|
March 10, 2023
Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis
Hertzel C Gerstein, Shun-Fu Lee, Guillaume Paré, et al.
Diabetes Research and Clinical Practice
|
May 27, 2021
Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020
Nikolaus Marx, Lars Ryden, Frank Brosius, et al.
American Heart Journal
|
June 23, 2014
Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial
Rury R Holman, Mary A Bethel, Juliana C N Chan, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
August 24, 2022
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial
Andre Lamy, John Eikelboom, Wesley Tong, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
December 28, 2023
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
Andre Lamy, John Eikelboom, Wesley Tong, et al.
Diabetes & Vascular Disease Research
|
October 21, 2017
Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes
Stefano Savonitto, Nuccia Morici, Anna Nozza, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Journal of the American College of Cardiology
|
February 25, 2003
Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system
Philip B Adamson, Anthony Magalski, Frieder Braunschweig, et al.
Circulation
|
September 28, 2011
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)
Giuseppe Mancia, Helmut Schumacher, Josep Redon, et al.
Global Heart
|
August 28, 2019
A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes
Sharon Mitchell, Belma Malanda, Albertino Damasceno, et al.
Diabetes Care
|
April 9, 2013
Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE)
Eva M Lonn, Jackie Bosch, Rafael Diaz, et al.
Diabetes Care
|
March 10, 2023
Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis
Hertzel C Gerstein, Shun-Fu Lee, Guillaume Paré, et al.
Diabetes Research and Clinical Practice
|
May 27, 2021
Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020
Nikolaus Marx, Lars Ryden, Frank Brosius, et al.
American Heart Journal
|
June 23, 2014
Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial
Rury R Holman, Mary A Bethel, Juliana C N Chan, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
August 24, 2022
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial
Andre Lamy, John Eikelboom, Wesley Tong, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
December 28, 2023
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
Andre Lamy, John Eikelboom, Wesley Tong, et al.
Diabetes & Vascular Disease Research
|
October 21, 2017
Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes
Stefano Savonitto, Nuccia Morici, Anna Nozza, et al.
Page
of 5